Compare Pollux Properties Indonesia Tbk. (POLL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pollux Properties Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Pollux Properties Indonesia Tbk. trades at Rp112 (market cap 931.71B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Pollux Properties Indonesia Tbk. is far larger — about 8.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| POLL | SCPI | |
|---|---|---|
Market Cap | 931.71B | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pollux Properties Indonesia Tbk.
PT Pollux Properti Indonesia, Tbk (the "Company" or "Parent Company") established on Jakarta based on the Notarial Deed No. 40 dated December 16, 2014 by Ferdinandus Indra Santoso Atmajaya, S.H., M.H., as a substitute of Notary Esther Mercia Sulaiman, S.H., a notary in Jakarta.
Read more on POLL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
